retatrutide news october 2025 the wonder drug: What's Established, What's Plausible, What's Still a Hypothesis — WellFounded - Founders Health & Concierge Performance Medicine Retatrutide Shows 28% Weight Loss

Ultra-processed, high-fat, really indulgent meals at quick serves just arent going to resonate. As a general rule of thumb, patients taking GLP-1 medications are advised to eat smaller portions with high protein and fiber content while avoiding high-fat, sugary and ultra-processed foods

In the SURPASS-2 trial, fasting insulin dropped by an average of 46% at 40 weeks (Frias et al., New England Journal of Medicine , 2021)

Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials, I Pera Calvi, 2023 How Do Semaglutide and Tirzepatide Compare for Weight Loss

In conditions like Long COVID and ME/CFS, the body fails to return to homeostasis after the initial infection clears